Rua Bioscience Ltd.NZX: RUA

RUA: Revenue surged, losses narrowed, and a capital raise is planned to fund further growth

· Issued by Rua Bioscience Ltd.

The meeting highlighted strong revenue growth, reduced losses, and expansion into five markets, while emphasizing the need for a NZD 2 million capital raise and the sale of a manufacturing facility to support ongoing operations. All resolutions were supported, and the board remains focused on cost control and strategic growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Rua Bioscience

All Rua Bioscience news releases